Table: begin end state 1 11 cytoplasmic 12 29 transmembrane 30 35 non-cytoplasmic 36 58 transmembrane 59 89 cytoplasmic 90 113 transmembrane 114 119 non-cytoplasmic 120 140 transmembrane 141 149 cytoplasmic 150 170 transmembrane 171 188 non-cytoplasmic 189 209 transmembrane 210 221 cytoplasmic 222 247 transmembrane 248 266 non-cytoplasmic 267 291 transmembrane 292 318 cytoplasmic 319 339 transmembrane 340 350 non-cytoplasmic 351 371 transmembrane 372 382 cytoplasmic 383 402 transmembrane 403 407 non-cytoplasmic 408 426 transmembrane 427 461 cytoplasmic
Input: >PfGW456L13_3775 MSVAKKMSVGQLTMLTAVNMLGSGIVLLPTKLAEVGAISILSWLITATGSLALAYAFARC GMLSRKTGGMGGYAEYTFGKAGNYITNYTYGLSLLIANVAISITAVGYIQVLFGIELDSL QVGLATIALLWITTFANFGGASITGRIGAVTVWGVIAPVVLVSTVGWFWFDSSVYAAGWN PHDKGWFEAAGASVAITLWAFLGLESACANTDAVENPERNVPIAVLGGTLGAAVIYIVST NVIFGIVGNEELAASTAPFGLVFAKMFTPMVGDIVMAAMVLACIGSLLGWQFTIAQVYKS SADTGYFLPIFAKGNKAGTPIVGMLVLLAAQTALALLTISPDLSKQFDTLVNLAVVTNLV PYILSMAALMTMQKVSNVPEGKALATNVIALIAAAYSYLALYSSGEQALMLGGVATIVGY TLFGFVNNRLIRLEALNNSVPTQTVSAQHLTAEPVPVNNLN
Or try the official Phobius web server, which has a different display
Reference: Advantages of combined transmembrane topology and signal peptide prediction - the Phobius web server